Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[111In]In-AMTG-DA1
- Development stage
- Unknown
- Lead developer
- Kyoto University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
01
Overview
[111In]In-AMTG-DA1: sourced facts only. name: "[111In]In-AMTG-DA1 showed marked binding ability to albumin, high affinity for GRPR, and high-level stability in vitro." [PMID:40365411]; target: "[111In]In-AMTG-DA1 showed marked binding ability to albumin, high affinity for GRPR, and high-level stability in vitro." [PMID:40365411]; developer: "Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan." [PMID:40365411]; modality: "we designed and synthesized a novel GRPR-targeted radioligand [111In]In-AMTG-DA1 containing an ALB moiety to improve tumor accumulation." [PMID:40365411]
02
Targets
GRPR (Gastrin-releasing peptide receptor)
Beyond the preview
Go deeper on [111In]In-AMTG-DA1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [111In]In-AMTG-DA1.